PEPT (Regenerex Pharma) Other Long-Term Liabilities : $-0.00 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerex Pharma Other Long-Term Liabilities?

Regenerex Pharma's other long-term liabilities for the quarter that ended in Jun. 2024 was $-0.00 Mil.

Regenerex Pharma's quarterly other long-term liabilities increased from Dec. 2023 ($-0.00 Mil) to Mar. 2024 ($0.00 Mil) but then declined from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil).

Regenerex Pharma's annual other long-term liabilities declined from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($-0.00 Mil) but then increased from Mar. 2023 ($-0.00 Mil) to Mar. 2024 ($0.00 Mil).

Regenerex Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Regenerex Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerex Pharma Other Long-Term Liabilities Chart

Regenerex Pharma Annual Data

Trend

Nov10

Nov11

Nov12

Nov13

Nov14

Mar17

Mar18

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Regenerex Pharma Quarterly Data
	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Regenerex Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Regenerex Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Regenerex Pharma Inc (OTCPK:PEPT) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108

Website

https://regenerexpharmainc.com

Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the Company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Regenerex Pharma Headlines

No Headlines